Universita degli Studi G. d'Annunzio Chieti e Pescara
Chieti, 66100, Italy
NCT Number: NCT02407730
Both hereditary and acquired thrombophilia have been associated with recurrent miscarriage and pregnancy complications. Thrombophilia could favor the development of thrombosis of the maternal vasculature and obstacle placentation. Some studies have suggested a role of thrombophilia in the failure of assisted reproductive techniques although this association has been recently questioned. The scope of this study is to evaluate the effect of thrombophilia on the implantation rate and live birth rate in women undergoing ART.
Design: prospective, observational study Primary end-point: live birth rate. Secondary end-points: implantation rate, venous thromboembolic events during ART up to 6 weeks post-partum
Looking for future studies?
Notify Me18 year and older
Female
Observational
Chieti, 66100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Participants will be followed for the duration of the pregnancy, an expected average of 9 months
Time frame: Participants will be followed from the implantation to the ultrasonography to document the gestational sac, an expected average of 7 weeks
G. d'Annunzio University
Other
EFFects of Thrombophilia on the Outcomes of Assisted Reproduction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03682419
Antiphospholipid Syndrome, Arrhythmias, Cardiac
Glasgow, United Kingdom
View Trial DetailsNCT00883272
Cardiovascular Diseases, Embolism and Thrombosis
New York, United States
View Trial DetailsNCT05225155
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Santo André, São Paulo, Brazil
View Trial DetailsNCT02139670
Hematologic Diseases, Hemic and Lymphatic Diseases
Afula, Israel
View Trial Details